Business Standard

Friday, December 20, 2024 | 10:05 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Banks make a beeline at Covid vaccine makers' doorstep to offer loans

Amid feeble credit offtake due to local lockdowns this year, lenders sanction Rs 6,000-crore line of credit to SII

vaccination, coronavirus, covid-19, vaccine
Premium

Manojit Saha Mumbai
Commercial banks are rushing to coronavirus vaccine manufacturers to offer them funds after the Reserve Bank of India (RBI) opened a liquidity tap of Rs 50,000 crore last week, which is available ‘on-tap’ for the lenders for on-lending to the healthcare sector.

According to banking industry sources, a host of commercial banks – both public sector and private sector – have sanctioned a line of credit to the tune of Rs 6,000 crore to Pune-based Serum Institute of India (SII) – the largest vaccine producer of the world, which is manufacturing Covishield vaccine. Sources indicate that SII has drawn Rs

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in